Prospective analysis of AR-V7 expression in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) sequentially treated with docetaxel and enzalutamide. This is an ASCO Meeting ...

The new Sassun-Mayo staging system, which integrates tumor deposit and lymph node counts, improves prognostic accuracy for patients with colon cancer compared with the standard American Joint ...

It may come as no surprise that breast cancer is the most common cancer in women worldwide. In the United States, about 275,000 women are diagnosed with breast cancer each year. Triple-negative breast ...

In the phase 3 EMBARK trial, enzalutamide plus leuprolide and enzalutamide monotherapy were associated with longer metastasis-free survival than leuprolide alone among patients with biochemically ...

Tukysa, combined with Herceptin and Perjeta, extends progression-free survival in HER2+ metastatic breast cancer, showing benefits across various patient subgroups. At the 2025 SABCS, researchers ...

The role of postmastectomy chest-wall irradiation in patients with breast cancer classified as pN1 (with involvement of one to three axillary nodes) or pN0 (pathologically node negative) with ...

Cancer cells survive therapy by dynamically rewiring their metabolism in response to nutrient availability, ...

Share on Pinterest A new study shows that a three-year exercise program improved colon cancer survival rates after treatment. Mapodile/Getty Images Researchers report that a three-year exercise ...

Amgen's bemarituzumab trial has taken a turn, with a final analysis showing weaker survival benefits than previously found in an earlier pre-specified interim analysis. In June, Amgen and China ...